rosiglitazone has been researched along with eye in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazim, M; Levin, F; Marcovici, E; Smith, TJ | 1 |
| Jiang, RZ; Li, QN; Yu, MB; Zheng, KK | 1 |
| Biagi, C; Marchesini, G; Marra, A; Motola, D; Piccinni, C; Poluzzi, E; Raschi, E | 1 |
3 other study(ies) available for rosiglitazone and eye
| Article | Year |
|---|---|
Rosiglitazone-induced proptosis.
Topics: Diabetes Mellitus, Type 2; Exophthalmos; Eye; Female; Humans; Hypoglycemic Agents; Middle Aged; Rosiglitazone; Thiazolidinediones; Thyroid Function Tests; Tomography, X-Ray Computed; Weight Gain | 2005 |
[Effect of Rosiglitazone on the proliferation and the production of transforming growth factor-beta 1 in cultured human Tenon' s capsule fibroblasts].
Topics: Cell Proliferation; Cells, Cultured; Eye; Fibroblasts; Humans; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1 | 2008 |
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
Topics: Adverse Drug Reaction Reporting Systems; Bone and Bones; Cardiovascular System; Clinical Trials as Topic; Databases, Factual; Eye; Female; Fractures, Bone; Humans; Hypoglycemic Agents; Macular Edema; Male; Meta-Analysis as Topic; Myocardial Infarction; Odds Ratio; Pioglitazone; Risk; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration | 2012 |